◀ Back to IFNB1

IFNB1 — NAB2

Text-mined interactions from Literome

Bertolotto et al., Neurology 2003 (Multiple Sclerosis) : Every 3 months, IFNbeta induced neutralizing antibodies ( NAb ) were evaluated in sera using a cytopathic effect assay
Chiu et al., Clin Exp Immunol 2007 (Multiple Sclerosis, Relapsing-Remitting) : In the present study, we describe the effect of NAb on IFN-beta-1b through clinical and magnetic resonance imaging ( MRI ) outcome measures of five relapsing remitting multiple sclerosis ( RRMS ) patients who were treated with 250 mug of subcutaneously administered IFN-beta-1b every other day and developed NAb at varying titres and times during the course of therapy